Tom Whitehead knows which medicine works to treat his Crohn’s disease. But when he switched insurers in 2025, he says was denied coverage for the expensive medication, Remicade, which he received in a monthly infusion. He was instead put on what’s called a biosimilar, which is essentially a slightly different version of the drug made from the same ma...
This is the feed from